Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRD4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastoma
Xianbing Zhang, Xinyi Guo, Ran Zhuo, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 604, pp. 63-69
Open Access | Times Cited: 13

Showing 13 citing articles:

New Approaches Towards Targeted Therapy for Childhood Neuroblastoma
Tina Dalianis, Monika Lukoseviciute, Stefan Holzhauser, et al.
Anticancer Research (2023) Vol. 43, Iss. 9, pp. 3829-3839
Open Access | Times Cited: 17
PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities
Xuelian Liu, Anjin Wang, Yuying Shi, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1217-1217
Open Access | Times Cited: 13
Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review)
Voraporn Yongprayoon, Napasporn Wattanakul, Winnada Khomate, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 3
Exosome-mediated secretion of miR-127-3p regulated by RAB27A accelerates metastasis in renal cell carcinoma
Dae Hyun Song, Jong Sil Lee, Jeong-Hee Lee, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
MYCN as an oncogene in pediatric brain tumors
Ana Patiño-Garcı́a, Jennifer Jackson, Prashanth G. Iyer, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Dysregulation of Transfer RNA-derived Small RNAs that Regulate Cell Activity and its Related Signaling Pathways in Human Cancers
Shuai Fang, Kaitai Liu, Tianyi Huang, et al.
Current Gene Therapy (2023) Vol. 23, Iss. 4, pp. 291-303
Closed Access | Times Cited: 7
Targeting the ubiquitin-proteasome system: a novel therapeutic strategy for neuroblastoma
Yangshen He, Jianing Wang, Tiantian Xiao
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases
Dalila Boi, Elisabetta Rubini, Sara Breccia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4746-4746
Open Access | Times Cited: 6
Super-enhancer-associated INSM2 regulates lipid metabolism by modulating mTOR signaling pathway in neuroblastoma
Haibo Cao, Ran Zhuo, Zimu Zhang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
Si-qi Jia, Ran Zhuo, Zi-Mu Zhang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 7
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma
Gen Li, Liya Ma, Chenxi Feng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Histone H3 Variants in the Multiverse of Cancer
Iva Simeonova, Geneviève Almouzni
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 453-474
Open Access | Times Cited: 1
Promising Molecular Targets and Novel Therapeutic Approaches in Neuroblastoma
Xu Yang, Jixia Li, Jigang Yang
Current Pharmacology Reports (2022) Vol. 9, Iss. 1, pp. 43-58
Open Access | Times Cited: 4
Combination bromo- and extraterminal domain and poly (ADP-ribose) polymerase inhibition synergistically enhances DNA damage and inhibits neuroblastoma tumorigenesis
Jillian C. Jacobson, Jingbo Qiao, Rachael A. Clark, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top